sodium arsenite has been researched along with Degenerative Diseases, Central Nervous System in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyd, JD; Concannon, J; Ebata, A; Feiler, MS; Glicksman, MA; Lee, P; Liu, M; Wolozin, B; Zauur, N | 1 |
1 other study(ies) available for sodium arsenite and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
A high-content screen identifies novel compounds that inhibit stress-induced TDP-43 cellular aggregation and associated cytotoxicity.
Topics: Animals; Animals, Genetically Modified; Arsenites; Caenorhabditis elegans; Cell Line; DNA-Binding Proteins; Drug Discovery; Drug Evaluation, Preclinical; Gene Expression; Genes, Reporter; High-Throughput Screening Assays; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Recombinant Fusion Proteins; Small Molecule Libraries; Sodium Compounds; Stress, Physiological | 2014 |